uroflowmetry


Also found in: Acronyms.

uroflowmetry

 [u″ro-flo´met-re]
the graphic representation of urinary flow, expressed as cubic centimeters per second; called also flow study and urinary flow study.

uroflowmetry

[yoo͡r′′ōflō′mətrē]
continuous recording of urine flow by means of a device consisting of a cylinder placed on a transducer that weighs the urine entering the cylinder during voiding and plots the flow rate on a time scale. Also called flow study.

uroflowmetry

(ū″rō-flō′mĕ-trē)
Timed measurement of the rate of urination. Uroflowmetry is used to diagnose conditions that result in slow urinary output, e.g., bladder outlet obstruction resulting from enlargement of the prostate gland. The maximal volume of urinary flow over time is called the Qmax. A Qmax of less than 10 ml of urine/second is an indication of significantly reduced urinary output.
References in periodicals archive ?
Clinical improvement and positive changes in the ultrasound and uroflowmetry parameters in patients with CP/CPPS who used DATD could be explained by positive changes in the prostate at the capillary level.
Abnormal uroflowmetry was defined as the presence of peak urine flow less than 20 mL/sec measured by an uroflowmeter.
Keywords: Uroflowmetry, Position-related change, Healthy young men.
Uroflowmetry, which is less invasive and easy to perform, was used for follow-up of the patient.
prostate volume, mean voided urine volume and free uroflowmetry (Qmax), as part of noninvasive urodynamic studies.
Uroflowmetry is the essential diagnostic test in dysfunctional voiding, and a staccato urine flow pattern is the mainstay of diagnosis.
MMS has been producing urodynamic systems for more than 20 years, including Alpha(TM), Solar(TM), Solar Blue(TM) Urodynamics Systems and Flowmaster(TM) and Flowstar(TM) Uroflowmetry products.
Follow up The follow up consisted of a history and level of satisfaction of the patient and protection if any used post operatively, clinical examination of vaginal and skin wound, uroflowmetry and USG for the residual urinary volume.
Using repeated measures of symptom score, uroflowmetry and prostate specific antigen in the clinical management of prostate disease.
Assessments included prostate volume (PV) by transrectal ultrasound (TRUS), maximum flow rate (Qmax) on uroflowmetry, post-void residual urine volume (PVR), International Prostate Symptom Score (IPSS), prostate specific antigen (PSA) levels, serum chemistry, and adverse events.